Leishmaniasis

Leishmaniasis is an infectious disease caused by microscopic parasites of the genus Leishmania. These parasites live inside the bodies of certain sandflies and are transmitted to humans through the fly’s bite. Once inside the skin or bloodstream, the parasites multiply within white blood cells, leading to a range of health problems. Leishmaniasis most commonly affects the skin, mucous membranes, and internal organs, depending on the species involved and the body’s immune response. In simple terms, it’s like having tiny invaders that hijack your immune cells, causing sores, swelling, and, in severe cases, damage to vital organs.

Leishmaniasis is considered “evidence-based” because its diagnosis, treatment, and prevention rest on decades of clinical research, laboratory studies, and public health data. Researchers have identified over 20 species of Leishmania, each linked to specific geographic regions and clinical forms of the disease. Global health authorities such as the World Health Organization manage surveillance programs and treatment guidelines to control outbreaks and improve patient outcomes. Understanding leishmaniasis involves knowing both the parasite’s biology and the human factors—like nutrition, housing, and immunity—that influence how the disease develops and spreads.

---

Types of Leishmaniasis

Leishmaniasis presents in several forms, each with distinct signs and severity:

1. Cutaneous Leishmaniasis
   The most common form, cutaneous leishmaniasis causes skin sores or ulcers at the site of the sandfly bite. These wounds can be painful or painless and may leave scars that last a lifetime.

2. Mucocutaneous Leishmaniasis
   This form begins as a skin lesion but spreads to mucous membranes of the nose, mouth, and throat. Over time, it can erode tissues and lead to disfigurement.

3. Visceral Leishmaniasis (Kala-Azar)
   The most severe form, visceral leishmaniasis affects internal organs such as the liver, spleen, and bone marrow. Symptoms include fever, weight loss, enlarged organs, and anemia. Without treatment, it can be fatal.

4. Diffuse Cutaneous Leishmaniasis
   A rare, widespread skin infection that produces multiple lesions across the body. It is often seen in people with weakened immune systems and is difficult to treat.

5. Post–Kala-Azar Dermal Leishmaniasis (PKDL)
   Occurring months or years after successful treatment of visceral leishmaniasis, PKDL causes persistent skin lesions that can serve as reservoirs for new infections.

---

Causes and Risk Factors

Although leishmaniasis itself is caused by Leishmania parasites, a variety of conditions and behaviors influence the risk of acquiring the disease. Here are twenty factors that contribute to infection:

1. Sandfly Bites
   The fundamental cause—being bitten by an infected female sandfly. These tiny, nocturnal insects feed on human blood to develop their eggs.

2. Living in Endemic Areas
   Residing in or visiting regions where leishmaniasis is common (parts of South America, the Mediterranean, Africa, and Asia) increases exposure risk.

3. Poor Housing Conditions
   Homes without screens, window protection, or solid walls allow sandflies to enter easily, raising infection chances.

4. Deforestation
   Clearing forests disrupts sandfly habitats, often bringing flies and humans into closer contact in newly settled areas.

5. Climate Change
   Rising temperatures and altered rainfall patterns can expand sandfly habitats into previously unaffected regions.

6. Malnutrition
   Poor nutrition weakens immune defenses, making the body less able to fight off Leishmania parasites.

7. Poverty
   Limited access to healthcare, insecticide-treated nets, and protective measures heightens vulnerability.

8. Migration and Displacement
   Refugees or migrants moving from non-endemic to endemic regions or vice versa can spread or acquire the disease.

9. HIV Coinfection
   People with HIV have compromised immunity that allows Leishmania to multiply rapidly, leading to severe disease.

10. Occupational Exposure
    Farmers, soldiers, or workers in forests and caves may encounter higher sandfly populations.

11. Urbanization
    Rapid, unplanned city growth without adequate sanitation and housing draws sandflies into urban settings.

12. Animal Reservoirs
    Dogs, rodents, and other mammals can harbor Leishmania, maintaining parasite cycles near human populations.

13. Poor Waste Management
    Piles of organic refuse provide breeding sites for sandflies and rodents, facilitating parasite spread.

14. Lack of Insect Repellents
    Not using repellents or protective clothing at dusk and dawn exposes skin to sandfly bites.

15. Weak Public Health Infrastructure
    Insufficient disease surveillance, diagnosis, and treatment services allow outbreaks to grow unchecked.

16. Immunosuppressive Treatments
    Medications like corticosteroids or chemotherapy reduce immune function, elevating infection risk.

17. Gender and Age
    In some regions, adult males working outdoors are more exposed; children’s immature immunity may also play a role.

18. Household Clustering
    Living in close quarters with someone infected can increase sandfly attraction to the household.

19. Genetic Susceptibility
    Certain genetic profiles may influence immune response effectiveness against Leishmania.

20. Lack of Vaccination
    No widely available vaccine exists yet, so absence of immunization keeps populations susceptible.

---

Symptoms

Symptoms vary by form of leishmaniasis, but here are fifteen common signs to watch for:

1. Skin Lesions
   Raised, red bumps or nodules at the bite site that may ulcerate.

2. Ulcers
   Open sores with a central crater, often painless but prone to infection.

3. Scarring
   Healed ulcers can leave permanent scars, affecting appearance and self-esteem.

4. Nasal Congestion
   In mucocutaneous forms, nasal passages swell and block airflow.

5. Bleeding of Mucous Membranes
   The nose or gums may bleed due to tissue erosion.

6. Mucosal Lesions
   White or red patches inside the mouth, nose, or throat.

7. Fever
   Persistent, low-grade fever common in visceral leishmaniasis.

8. Weight Loss
   Chronic infection often leads to wasting and malnutrition.

9. Enlarged Spleen (Splenomegaly)
   The spleen grows as it works to filter infected cells from the bloodstream.

10. Enlarged Liver (Hepatomegaly)
    The liver may also swell in visceral disease, causing abdominal discomfort.

11. Anemia
    Low red blood cell counts result from bone marrow invasion by parasites.

12. Fatigue
    Weakness and exhaustion stem from anemia and chronic infection.

13. Night Sweats
    Drenching sweats during sleep, reflecting systemic inflammation.

14. Lymph Node Swelling
    Enlarged, tender lymph nodes near infected skin or throughout the body.

15. Cough and Shortness of Breath
    In severe visceral cases, lung involvement may cause respiratory symptoms.

---

Diagnostic Tests

Diagnosing leishmaniasis requires a mix of clinical evaluation and laboratory confirmation. Below are twenty tests grouped by category, each explained in simple terms:

Physical Exam

1. Skin Inspection
   A doctor looks closely at sores for typical ulcer shape and location.

2. Mucosal Examination
   Inspection of nose, mouth, and throat for erosions or growths.

3. Abdominal Palpation
   Feeling the belly to detect enlarged liver or spleen by touch.

Manual (Bedside) Tests

4. Montenegro Skin Test
   Injects a tiny amount of killed parasite under the skin; a reaction indicates prior exposure.

5. Needle Aspiration
   A thin needle collects fluid or cells from a lesion for microscopic review.

6. Slit-Skin Smear
   A small slice of skin lesion is smeared on a slide to look for parasites.

Laboratory and Pathological Tests

7. Microscopy of Biopsy
   Tissue taken from a lesion is stained and examined for Leishmania under a microscope.

8. Culture of Parasite
   Cells from lesions are grown in a special medium to multiply parasites for confirmation.

9. Polymerase Chain Reaction (PCR)
   A DNA test that amplifies parasite genetic material to detect even small numbers.

10. Serological Tests (Direct Agglutination Test)
    Blood is mixed with parasite antigens—if antibodies clump the parasites, the test is positive.

11. Enzyme-Linked Immunosorbent Assay (ELISA)
    Measures antibodies in the blood that the body makes against Leishmania.

12. Rapid Diagnostic Tests (RDTs)
    Simple kits that give results in minutes by detecting parasite proteins in blood.

Electrodiagnostic Tests

1. Nerve Conduction Studies
   Measures how fast electrical signals travel through nerves near lesions.
2. Electromyography (EMG)
   Records electrical activity of muscles to check for parasite-related nerve damage.

Imaging Tests

15. Ultrasound of Abdomen
    Uses sound waves to visualize spleen and liver size in visceral disease.

16. Chest X‑Ray
    Detects lung involvement if respiratory symptoms are present.

17. Computed Tomography (CT) Scan
    Detailed cross‑sectional images of organs to assess internal damage.

18. Magnetic Resonance Imaging (MRI)
    High‑resolution images help evaluate deep tissue lesions or mucosal spread.

19. Positron Emission Tomography (PET) Scan
    Shows areas of inflammation and parasite activity inside the body.

20. Lymphangiography
    Injects dye into lymph vessels to map blockage or enlargement around lesions.

Non‑Pharmacological Treatments

Below are 20 treatments that do not rely on conventional anti‑parasitic drugs. Each relies on physical, mechanical, nutritional or psychosocial methods to help control or heal leishmaniasis lesions.

1. Infrared Light Thermotherapy

   • Description: Uses infrared lamps to heat lesions to 50–55 °C for a few seconds.

   • Purpose: Kills parasites locally without drugs.

   • Mechanism: Heat induces parasite protein denaturation and death in the skin PMC.

2. Laser Therapy

   • Description: Continuous‐wave or pulsed lasers (e.g., Nd:YAG) are focused on ulcers.

   • Purpose: Ablates infected tissue with precision.

   • Mechanism: Laser energy creates photothermal destruction of parasites and host necrotic tissue PMC.

3. Radiofrequency Hyperthermia

   • Description: Radiofrequency probes deliver controlled heat to lesions.

   • Purpose: Alternative method to thermotherapy.

   • Mechanism: Electromagnetic waves raise tissue temperature to kill parasites PMC.

4. Hot Water Soaks

   • Description: Immersing lesions in water at 39–42 °C for 20–30 minutes daily.

   • Purpose: Low‑cost heating therapy in field settings.

   • Mechanism: Mild heat stresses parasites over repeated sessions PMC.

5. Carbon Dioxide Laser Ablation

   • Description: CO₂ laser vapourizes necrotic tissue layer by layer.

   • Purpose: Removes deep lesions with minimal bleeding.

   • Mechanism: High‑intensity infrared light causes instantaneous vaporization of water in cells, destroying parasites PMC.

6. Cryotherapy

   • Description: Liquid nitrogen applied to lesions in freeze–thaw cycles.

   • Purpose: Simple, rapid clinic‑based therapy.

   • Mechanism: Ice crystals form inside cells, rupturing parasite and host cell membranes PMC.

7. Photodynamic Therapy (PDT)

   • Description: A photosensitizing agent is applied, followed by light activation.

   • Purpose: Kills parasites via reactive oxygen species.

   • Mechanism: Light‐activated photosensitizer generates free radicals that damage parasite membranes and DNA PubMed.

8. Sonodynamic Therapy

   • Description: Ultrasound plus a sonosensitizer (e.g., rose bengal) applied to lesions.

   • Purpose: Deep tissue treatment where light cannot reach.

   • Mechanism: Ultrasound waves activate the sensitizer, producing cytotoxic species turkiyeparazitolderg.org.

9. Ultrasound‑Induced Hyperthermia

   • Description: High‑frequency ultrasound probes applied over ulcers.

   • Purpose: Noninvasive localized heating.

   • Mechanism: Ultrasound converts to heat energy at depth, killing parasites ResearchGate.

10. Hyperbaric Oxygen Therapy

    • Description: Patients breathe 100% oxygen in a pressurized chamber.

    • Purpose: Enhances oxygen delivery to hypoxic lesions.

    • Mechanism: High oxygen tensions boost reactive oxygen species in macrophages, aiding parasite killing and wound healing PubMed.

11. Wound Debridement and Standard Wound Care

    • Description: Regular removal of dead tissue, gentle cleaning and sterile dressings.

    • Purpose: Prevents secondary infection and promotes healthy granulation.

    • Mechanism: Physical removal of necrotic tissue reduces parasite burden and allows new tissue growth Cleveland Clinic.

12. Nutritional Counseling and Support

    • Description: Diet plans ensuring adequate protein, calories and micronutrients.

    • Purpose: Strengthens overall immunity.

    • Mechanism: Corrects malnutrition, which otherwise impairs cell‑mediated immunity World Health Organization.

13. Psychological and Social Support Services

    • Description: Counseling and support groups for patients with disfiguring scars.

    • Purpose: Addresses stigma, depression and quality‑of‑life issues.

    • Mechanism: Improves treatment adherence and coping through emotional support World Health Organization.

14. Patient Education on Wound Care Techniques

    • Description: Teaching patients how to clean, dress and monitor lesions at home.

    • Purpose: Empowers self‑care and early detection of complications.

    • Mechanism: Reduces delays in seeking further treatment by spotting warning signs early Cleveland Clinic.

15. Community Health Education and Behavior Change

    • Description: Village meetings, leaflets and radio programs on leishmaniasis prevention and care.

    • Purpose: Promotes early presentation and reduces transmission risk.

    • Mechanism: Increases awareness, leading to protective behaviors and timely clinic visits World Health Organization.

16. Supportive Therapy for Malnutrition, Anemia and Infections

    • Description: Iron and folate supplementation, treatment of co‑infections (e.g., malaria, helminths).

    • Purpose: Addresses systemic factors that worsen VL outcomes.

    • Mechanism: Correcting anemia and infections improves tolerance to therapy and immune function CDC.

17. Environmental Management and Hygiene

    • Description: Ensuring living areas are clean, dry and free of organic debris.

    • Purpose: Reduces risk of secondary bacterial infection and reinfestation.

    • Mechanism: Less favorable conditions for sand flies and bacteria around lesions World Health Organization.

18. Social Mobilization and Strengthening Partnerships

    • Description: Coordinated efforts among health services, NGOs and community leaders.

    • Purpose: Integrates case finding, treatment and prevention into broader health systems.

    • Mechanism: Multi‑sectoral collaboration boosts resource allocation and program sustainability World Health Organization.

19. Monitoring and Follow‑Up with Clinical Photography and Telemedicine

    • Description: Periodic photographic documentation of lesions and remote expert consultation.

    • Purpose: Tracks healing progress and identifies treatment failures early.

    • Mechanism: Objective records guide decisions on therapy modifications PMC.

20. Occupational Therapy for Functional Adaptation

    • Description: Assistance with activities of daily living when lesions impair mobility (e.g., hand ulcers).

    • Purpose: Maintains independence and muscle strength during recovery.

    • Mechanism: Customized exercises and adaptive tools prevent contractures and disability.

---

Key Antileishmanial Drugs

1. Sodium Stibogluconate

   • Class: Pentavalent antimonial

   • Dosage: 20 mg Sb^V/kg/day IM or IV for 20 days (CL) or 28 days (ML/VL)

   • Timing: Once daily

   • Side Effects: Cardiotoxicity (arrhythmias), pancreatitis, elevated liver enzymes, myalgia CDCCDC.

2. Meglumine Antimoniate

   • Class: Pentavalent antimonial

   • Dosage: 20 mg Sb^V/kg/day IM for 20 days

   • Timing: Once daily

   • Side Effects: Similar to sodium stibogluconate (arthralgia, myalgia, hepatotoxicity) CDC.

3. Liposomal Amphotericin B (AmBisome)

   • Class: Polyene antifungal

   • Dosage: Total 20 mg/kg, given as 3 mg/kg on days 1–5, 14 and 21 (total 21 mg/kg) or single 10 mg/kg dose for VL

   • Timing: As above

   • Side Effects: Infusion reactions (fever, chills), nephrotoxicity World Health OrganizationCDC.

4. Amphotericin B Deoxycholate

   • Class: Polyene antifungal

   • Dosage: 0.7–1.0 mg/kg/day IV for 15–20 days

   • Timing: Once daily

   • Side Effects: Renal impairment, infusion‑related fever, hypotension World Health Organization.

5. Pentamidine Isethionate

   • Class: Aromatic diamidine

   • Dosage: 2–3 mg/kg IM every other day × 7 doses (CL) or 4 mg/kg IM every other day × 15–30 doses (VL)

   • Timing: Every second day

   • Side Effects: Hypotension, nephrotoxicity, hypoglycemia, QT prolongation Drugs.comPubMed.

6. Miltefosine

   • Class: Alkyl phosphocholine

   • Dosage: 2.5 mg/kg/day PO (max 150 mg/day) for 28 days

   • Timing: Divided into two daily doses

   • Side Effects: Nausea, vomiting, headache, teratogenic—avoid in pregnancy WikipediaCDC.

7. Paromomycin

   • Class: Aminoglycoside

   • Dosage: 15 mg/kg/day IM for 21 days (VL) or topical 15% ointment twice daily × 20 days (CL)

   • Timing: Once daily (IM) or twice daily (topical)

   • Side Effects: Renal toxicity, ototoxicity, injection‑site pain PMC.

8. Fluconazole

   • Class: Azole antifungal

   • Dosage: 200–400 mg/day PO for 6 weeks (species‑dependent)

   • Timing: Once daily

   • Side Effects: Hepatotoxicity, QT prolongation PMCCDC.

9. Itraconazole

   • Class: Azole antifungal

   • Dosage: 200 mg PO twice daily for 28 days

   • Timing: Twice daily

   • Side Effects: Gastrointestinal upset, hepatotoxicity CDC.

10. Ketoconazole

    • Class: Azole antifungal

    • Dosage: 400–600 mg/day PO for 28 days

    • Timing: Once or twice daily

    • Side Effects: Endocrine disturbances, hepatotoxicity CDC.

---

Dietary Molecular Supplements

1. Zinc (2.5–10 mg/kg/day orally)

   • Function: Immune system support

   • Mechanism: Boosts Th1 response and oxidative burst in macrophages PubMed.

2. Vitamin A (20,000 IU/day)

   • Function: Epithelial integrity and immunity

   • Mechanism: Enhances macrophage function, barrier defenses PMC.

3. Selenium (100–200 µg/day)

   • Function: Antioxidant defense

   • Mechanism: Supports selenoprotein‑mediated free radical scavenging ScienceDirect.

4. Vitamin D (2,000 IU/day)

   • Function: Immunomodulation

   • Mechanism: Shifts cytokine profile toward parasite‑killing Th1 responses SpringerLink.

5. Vitamin C (500 mg twice daily)

   • Function: Collagen synthesis and antioxidant

   • Mechanism: Protects tissues and supports wound healing Cambridge University Press & Assessment.

6. Iron (30 mg elemental/day)

   • Function: Corrects anemia, supports oxygen transport

   • Mechanism: Ensures adequate hemoglobin and immune cell function ProQuest.

7. Curcumin (2,500 mg/day in nanoemulsion or 500 mg twice daily)

   • Function: Antiparasitic and anti‑inflammatory

   • Mechanism: Generates reactive oxygen species and modulates NF‑κB; topical CUR‑NE at 2.5 mg/mL reduced lesion size by 40% in mice BioMed Central.

8. Piperine (20 mg/day)

   • Function: Bioavailability enhancer for curcumin

   • Mechanism: Inhibits drug efflux pumps, supports immunomodulation SpringerLink.

9. Quercetin (500 mg twice daily topical or oral)

   • Function: Antioxidant

   • Mechanism: Generates oxidative stress against parasites SpringerLink.

10. L‑Arginine (3–6 g/day)

    • Function: Precursor for nitric oxide

    • Mechanism: Increases macrophage NO production, enhancing intracellular parasite killing PMC.

---

Immunomodulatory & Regenerative Therapies (6 “Stem‑Cell/Hard Immunity” Drugs)

1. Interferon‑Gamma (IFN‑γ)

   • Dosage: 50–100 µg/m² SC three times weekly, often with antimonials

   • Function: Potent macrophage activator

   • Mechanism: JAK–STAT signaling boosts nitric oxide–mediated parasite killing; reduces antimony dose and treatment duration New England Journal of MedicinePubMed.

2. Granulocyte‑Macrophage Colony‑Stimulating Factor (GM‑CSF)

   • Dosage: 10 µg/mL topically (1–2 mL) three times/week × 3 weeks or 5 µg/kg/day SC × 10 days

   • Function: Monocyte/macrophage recruitment

   • Mechanism: Increases tissue myelomonocytic infiltration and leishmanicidal activity PubMedSpringerLink.

3. Granulocyte Colony‑Stimulating Factor (G‑CSF)

   • Dosage: 400 µg intralesional on days 0 and 15

   • Function: Neutrophil proliferation

   • Mechanism: Enhances granulocyte‑mediated early parasite clearance; well tolerated MDPI.

4. Mesenchymal Stem Cell (MSC) Therapy

   • Dosage: 1×10^6 MSCs injected intralesionally on days 0 and 15

   • Function: Tissue repair and immunomodulation

   • Mechanism: MSCs secrete anti‑inflammatory cytokines (IL‑10, TGF‑β), enhance macrophage phagocytosis and lesion healing PubMed.

5. Adipose‑Derived MSC Therapy

   • Dosage: 2×10^6 cells intralesionally × 2 doses

   • Function: Similar to BM‑MSC but easier harvest

   • Mechanism: Boosts Th1 cytokines and accelerates re‑epithelialization; reduces parasite load BioMed Central.

6. MSC Secretome Therapy

   • Dosage: 100 µg/mL protein secretome applied topically or injected every 2–3 days for 2 weeks

   • Function: Regenerative support

   • Mechanism: Delivers growth factors (VEGF, HGF) and exosomes to promote angiogenesis and modulate local immunity ijms.sums.ac.ir.

---

Surgical Procedures

1. Lesion Excision

   • Procedure: Surgical removal of necrotic ulcer edges under local anesthesia.

   • Benefit: Immediate reduction of parasite burden and necrotic tissue, enabling faster healing.

2. Split‑Thickness Skin Grafting

   • Procedure: Harvesting superficial skin from thigh or buttock to cover large defects.

   • Benefit: Provides immediate wound coverage, reducing infection risk and fluid loss.

3. Local Flap Reconstruction

   • Procedure: Mobilizing adjacent healthy skin and subcutaneous tissue to cover excised lesions.

   • Benefit: Restores contour and function with similar‐textured skin.

4. Z‑Plasty Scar Revision

   • Procedure: Reorients scar lines using triangular flaps.

   • Benefit: Improves mobility, reduces contracture and cosmetic deformity.

5. Septal Perforation Repair

   • Procedure: Local mucosal flaps or grafts to close nasal septum defects in MCL.

   • Benefit: Restores nasal airflow and aesthetic form.

6. Rhinoplasty with Cartilage Grafting

   • Procedure: Harvesting cartilage (e.g., ear or rib) to reconstruct nasal framework.

   • Benefit: Corrects saddle‑nose deformity and protects nasal function.

7. Mucosal Flap for Oral/Pharyngeal Lesions

   • Procedure: Buccal or palatal flaps to repair ulcerated mouth/throat areas.

   • Benefit: Improves speech, swallowing and reduces infection risk.

8. Eyelid Reconstruction

   • Procedure: Use of local skin or tarsal grafts to rebuild eyelid margins after ML.

   • Benefit: Protects the eye and preserves vision.

9. Dermal Fat Grafting

   • Procedure: Transferring dermis with attached fat into depressed scars.

   • Benefit: Restores volume and contour in atrophic scar areas.

10. Laser‑Assisted Excision

    • Procedure: CO₂ laser used to precisely remove lesion tissue under local anesthesia.

    • Benefit: Minimizes bleeding, reduces postoperative pain and scarring.

(Reconstructive surgery should be delayed until at least 3 months after confirmed parasitological cure to minimize graft failure and relapse risk) PMC.

---

Prevention Strategies

1. Insecticide‑Treated Bed Nets

   • Sleep under fine‑mesh (≤0.6 mm) nets treated with pyrethroids to block sand flies.

2. EPA‑Registered Repellents

   • Apply DEET or picaridin on exposed skin at dusk and dawn.

3. Protective Clothing

   • Wear long sleeves, long pants and closed shoes in endemic areas.

4. Indoor Residual Spraying

   • Regularly spray walls and animal shelters with insecticide.

5. Dog Collar Programs

   • Fit domestic dogs with deltamethrin‑impregnated collars to kill sand flies.

6. Reservoir Control

   • Identify and manage animal reservoirs (rodents, dogs) through vaccination or treatment.

7. Environmental Management

   • Remove organic debris, fill rodent burrows and improve sanitation to reduce sand‑fly breeding.

8. Community Education

   • Conduct awareness campaigns on personal protection and early treatment seeking.

9. Active Case Detection

   • Screen at‑risk populations to treat early cases and interrupt transmission.

10. Travel Advisories and Vaccination

    • Follow local public health travel advice; while no human vaccine is yet licensed, several candidates are in trials World Health Organization.

---

When to See a Doctor

Seek medical attention if you experience:

• Skin sores or ulcers in someone who lives in or has traveled to an endemic area.

• A wound that does not heal within 4–6 weeks after a suspected sand‑fly bite Cleveland Clinic.

• Facial or mucosal lesions (nose, mouth, throat) that impair breathing, speech or swallowing.

• Systemic symptoms such as prolonged fever (>39 °C), weight loss, night sweats or abdominal swelling from an enlarged spleen or liver.

• Weakened immunity (e.g., HIV/AIDS, immunosuppressive therapy) with any suspicious lesion or systemic symptoms.

• Signs of serious illness (high fever unresponsive to antipyretics, breathing difficulty, jaundice or cyanosis) — go to the emergency room immediately Cleveland Clinic.

---

Nutrition: What to Eat and What to Avoid

Eat:

1. Lean Proteins (chicken, fish, legumes) for tissue repair.

2. Fruits & Vegetables rich in vitamins A (carrots), C (citrus) and D (mushrooms).

3. Whole Grains (brown rice, oats) for energy and fiber.

4. Nuts & Seeds for healthy fats and trace minerals.

5. Yogurt & Fermented Foods for gut microbiome support.

6. Lean Red Meat or fortified cereals for iron.

7. Seafood for omega‑3 fatty acids and zinc.

8. Legumes & Nuts for plant‑based protein and micronutrients.

9. Hydration: plenty of water and electrolyte‑rich drinks.

10. Herbal Teas (e.g., ginger, turmeric) for mild anti‑inflammatory benefit ScienceDirect.

Avoid:

1. Processed Foods high in salt, sugar and trans fats.

2. Excessive Alcohol which impairs nutrient absorption.

3. Sugary Drinks that can worsen inflammation.

4. High‑Fat Fast Foods that burden the liver.

5. Unpasteurized Dairy carrying infection risk.

6. Raw or Undercooked Meat/Fish to avoid additional infections.

7. Excess Iron Supplements unless deficient, to prevent oxidative stress.

8. Unregulated “Herbal” Products without proven safety.

9. Excess Caffeine which may impair wound healing when overused.

10. Refined Carbohydrates for stable blood sugar support.

---

Frequently Asked Questions (FAQs)

1. What causes leishmaniasis?
   A parasite called Leishmania enters your body from the bite of infected sand flies. The parasites live and multiply inside certain white blood cells.

2. Is leishmaniasis contagious between people?
   No. It only spreads via sand‑fly bites. You cannot catch it by touching someone or from their lesions.

3. How long after a sand‑fly bite do symptoms appear?
   Cutaneous sores appear 2 weeks to several months after the bite; visceral symptoms can take months to develop.

4. Can cutaneous leishmaniasis heal on its own?
   Some small sores may eventually heal, but treatment speeds recovery, reduces scarring and prevents mucosal spread.

5. Is there a vaccine for leishmaniasis?
   No human vaccine is yet licensed, though several candidates are in clinical trials.

6. How is leishmaniasis diagnosed?
   By looking at tissue samples (biopsy, smear) under a microscope, or by PCR tests to detect parasite DNA.

7. What is the best treatment for visceral leishmaniasis?
   Liposomal amphotericin B (AmBisome) is first choice in most regions due to high cure rates and lower toxicity.

8. Are there oral treatments?
   Yes—miltefosine is the only widely available oral drug, effective for some CL and VL cases but not in pregnancy.

9. Can leishmaniasis come back after treatment?
   Relapse can occur, especially with mucocutaneous and visceral forms, so follow‑up is important.

10. How can I protect myself when traveling?
    Use insect repellents, treated bed nets, wear protective clothing and avoid outdoor activities at dusk and dawn in endemic areas.

11. Is leishmaniasis fatal?
    Cutaneous and mucocutaneous forms are rarely fatal but cause disfigurement. Visceral leishmaniasis is life‑threatening if untreated.

12. Who is at higher risk?
    People living in poor, rural areas, immunocompromised individuals (HIV/AIDS), and those with malnutrition.

13. Can pets spread leishmaniasis?
    Pets do not directly infect humans, but dogs can act as a reservoir so controlling canine infection helps reduce human cases.

14. Are non‑drug therapies effective?
    Mechanical therapies like thermotherapy and cryotherapy can cure some skin lesions, especially small or single ulcers.

15. When should I follow up after treatment?
    Patients should be re‑examined at 3 and 6 months post‑treatment to check for relapse and manage scars or complications.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 25, 2025.